Australian Clinical Labs Limited (ACL.AX)
Runs pathology labs that analyze blood and tissue samples for Australian doctors and patients.
2.43+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-10.3%
The outlook
ACL.AX is trading at $2.43 with analyst consensus leaning toward Buy. The stock sits above both its 50- and 200-day moving averages and roughly midway in its 52-week range, with the average analyst price target sitting about 6% above the current level.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Price targetAvg target +6% vs current price
Analyst price target
~12-month · 8 analysts2.57average target+5.8% vs now
Now 2.43
Low 2.20High 3.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$453.2M
52-wk high
2.97
52-wk low
1.83
50-day avg
2.19
200-day avg
2.35
Trailing P/E
17.4